Cargando…

A multicentre comparison of quantitative (90)Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

PURPOSE: To investigate and compare the quantitative accuracy of (90)Y imaging across different generation PET/CT scanners, for the purpose of dosimetry after radioembolization with resin microspheres. METHODS: A strict experimental and imaging protocol was followed by 47 international sites using t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willowson, Kathy P., Tapner, Michael, Bailey, Dale L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480824/ https://www.ncbi.nlm.nih.gov/pubmed/25967868 http://dx.doi.org/10.1007/s00259-015-3059-9

Ejemplares similares

Assessment of the relative contribution of volume and concentration changes in Yttrium-90 labelled resin microspheres on ionization chamber measurements
por: Forwood, Nicholas, et al.
Publicado: (2017)

Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
por: D’Arienzo, Marco, et al.
Publicado: (2017)

Multi institutional quantitative phantom study of yttrium-90 PET in PET/MRI: the MR-QUEST study
por: Maughan, Nichole M., et al.
Publicado: (2018)

A Comparison of Techniques for (90)Y PET/CT Image-Based Dosimetry Following Radioembolization with Resin Microspheres
por: Pasciak, Alexander S., et al.
Publicado: (2014)

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

Radioembolization with (90)Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy
por: Braat, A. J. A. T., et al.
Publicado: (2019)

Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC
por: Veenstra, Emile B., et al.
Publicado: (2022)

Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma
por: Kaya, Neslihan Arife, et al.
Publicado: (2023)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres
por: Depalo, Tommaso, et al.
Publicado: (2021)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
por: Gaba, Ron C., et al.
Publicado: (2012)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
por: Bunck, Alexander C., et al.
Publicado: (2017)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization
por: Elschot, Mattijs, et al.
Publicado: (2013)

Quantitative and Qualitative Assessment of Yttrium-90 PET/CT Imaging
por: Attarwala, Ali Asgar, et al.
Publicado: (2014)

Computational simulation of the predicted dosimetric impact of adjuvant yttrium-90 PET/CT-guided percutaneous ablation following radioembolization
por: Pasciak, Alexander S., et al.
Publicado: (2016)

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer
por: Cohen, S J, et al.
Publicado: (2014)

Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma—An Evaluation of Predictors
por: Paprottka, Karolin J., et al.
Publicado: (2021)

Radioembolization and the Dynamic Role of (90)Y PET/CT
por: Pasciak, Alexander S., et al.
Publicado: (2014)

Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with (90)Y microspheres
por: Yim, Sun Young, et al.
Publicado: (2014)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
por: Roshan, Hoda Rezaei, et al.
Publicado: (2015)

Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
por: Meyers, Nicolas, et al.
Publicado: (2020)

Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
por: Ebbers, S. C., et al.
Publicado: (2020)

Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma
por: Ghosh, Abheek, et al.
Publicado: (2022)

Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review
por: Alonso, J. C., et al.
Publicado: (2022)

Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 ((90)Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with (90)Y microspheres
por: Knešaurek, Karin, et al.
Publicado: (2018)

Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with (90)Y resin microspheres for chemo-refractory colorectal liver metastases
por: Fidelman, Nicholas, et al.
Publicado: (2022)

Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study
por: Maleux, Geert, et al.
Publicado: (2023)

Radiographic Parameters in Predicting Outcome of Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Microsphere Radioembolization
por: Salem, Mohamed E., et al.
Publicado: (2013)

A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma
por: Zhen, Yanhua, et al.
Publicado: (2019)

Feasibility of imaging (90)Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning
por: Kunnen, Britt, et al.
Publicado: (2020)

Towards personalised dosimetry in patients with liver malignancy treated with (90)Y-SIRT using in vivo-driven radiobiological parameters
por: Gholami, Yaser H., et al.
Publicado: (2022)

Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres
por: Melucci, Elisa, et al.
Publicado: (2013)

Clinical and Laboratory Toxicity after Intra-Arterial Radioembolization with (90)Y-Microspheres for Unresectable Liver Metastases
por: Smits, Maarten L. J., et al.
Publicado: (2013)

Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with (90)Y-Microspheres: A Systematic Review
por: Birgin, Emrullah, et al.
Publicado: (2020)

Economic evaluations of radioembolization with yttrium-90 microspheres in liver metastases of colorectal cancer: a systematic review
por: Alonso, JC, et al.
Publicado: (2023)

Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla
por: Sotirchos, Vlasios S., et al.
Publicado: (2014)

Diagnostic and prognostic value of (99m)Tc-MAA SPECT/CT for treatment planning of (90)Y-resin microsphere radioembolization for hepatocellular carcinoma: comparison with planar image
por: Son, Mai Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tb90a541rk3ama1koenuao7rne